Bank of New York Mellon Corp Boosts Stock Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)

Bank of New York Mellon Corp boosted its position in Viemed Healthcare, Inc. (NASDAQ:VMD) by 11.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 95,388 shares of the company’s stock after purchasing an additional 9,792 shares during the period. Bank of New York Mellon Corp owned about 0.25% of Viemed Healthcare worth $625,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in VMD. Vanguard Group Inc. boosted its holdings in Viemed Healthcare by 53.0% during the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock worth $16,803,000 after buying an additional 617,009 shares in the last quarter. Kent Lake Capital LLC acquired a new stake in shares of Viemed Healthcare in the 1st quarter worth approximately $5,557,000. Bard Associates Inc. grew its holdings in shares of Viemed Healthcare by 882.0% in the 4th quarter. Bard Associates Inc. now owns 338,335 shares of the company’s stock worth $2,656,000 after acquiring an additional 303,880 shares during the period. Millrace Asset Group Inc. purchased a new position in Viemed Healthcare in the 4th quarter valued at approximately $1,458,000. Finally, Penbrook Management LLC raised its holdings in Viemed Healthcare by 236.0% during the second quarter. Penbrook Management LLC now owns 231,607 shares of the company’s stock worth $1,517,000 after purchasing an additional 162,670 shares during the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Stock Down 0.3 %

Viemed Healthcare stock opened at $7.31 on Tuesday. Viemed Healthcare, Inc. has a fifty-two week low of $5.90 and a fifty-two week high of $10.44. The firm has a market capitalization of $283.78 million, a price-to-earnings ratio of 28.12 and a beta of 1.47. The stock’s fifty day moving average is $7.27 and its two-hundred day moving average is $7.56. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.29 and a current ratio of 1.43.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.03). The business had revenue of $54.97 million during the quarter. Viemed Healthcare had a net margin of 4.60% and a return on equity of 8.23%.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.